| Literature DB >> 15495245 |
Kenneth Christopher1, Clare Horkan, Ilie T Barb, Christian Arbelaez, Travis A Hodgdon, Paul C Yodice.
Abstract
Intravenous Rho (D) immune globulin (IV RhIG, WinRho SDF) has been shown to be a safe treatment for idiopathic thrombocytopenic purpura (ITP). Common side effects of IV RhIG include mild hemolysis, febrile reaction, and headache. Significant hemolysis with renal impairment following IV RhIG has been reported. We report a case of irreversible encephalopathy 48 hr following an infusion of IV RhIG for treatment of ITP.Entities:
Mesh：
Substances：
Year: 2004 PMID： 15495245 DOI： 10.1002/ajh.20189
Source DB: PubMed Journal: Am J Hematol ISSN： 0361-8609 Impact factor: 10.047